ARCHIVE SEARCH
      -OR-  
 
  NEWS CHANNELS
Fitness News
Asthma Allergy News
Diabetes News
Women's Health News
 > Men's Health News

  MY NEWS
Personal Archive
My Account

  ABOUT THIS NEWSFEED
About Us
Advertise With Us
Feed Your Site
Contact Us


Site Map
RSS News Feed 

  Website development & hosting
   by Cyber Software Solutions

 
Effect of Testosterone on CV Disease in Men Uncertain
Review of the literature conducted to assess low testosterone link to cardiovascular disease/mortality

FRIDAY, Sept. 27 (HealthDay News) -- Further research is required to determine the relationship between testosterone levels and cardiovascular disease in men and to explore the risk-benefit of testosterone therapy, according to a review published online Sept. 24 in the Journal of Clinical Endocrinology & Metabolism.

Johannes B. Ruige, M.D., of the Ghent University Hospital in Belgium, and colleagues reviewed literature published between 1970 and 2013 to assess the beneficial and adverse effects of testosterone on the cardiovascular system in men.

The researchers found that low testosterone levels in men are associated with increased blood pressure, dyslipidemia, atherosclerosis, thrombosis, endothelial dysfunction, arrhythmia, and impaired left ventricular function. Although evidence suggests a modest association between low levels of testosterone and cardiovascular disease and mortality in men, the benefit of testosterone therapy has not been established. Little evidence was found for a connection between low testosterone and artherosclerosis and no relationship was seen between testosterone levels and heart attacks.

"The important knowledge gap as to the exact relationship between testosterone and cardiovascular disease would support a cautious, restrained approach to testosterone therapy in aging men, pending clarification of benefits and risks by adequately powered clinical trials of sufficient duration," the authors write.

Abstract
Full Text (subscription or payment may be required)



Copyright © 2013 HealthDay. All rights reserved.


Back to Top Stories
  GOOGLE ADS